When all of the above has been completed, the material should be sent to the HRAC Office, Slot 636 . After each meeting, letters will be sent to the Principal Investigators informing them of the Committee's actions. Please be sure to include a mail slot number or return address. It is necessary that all material be submitted in triplicate plus the extra 35 copies to insure review by three committee members prior to the monthly meeting. The extra 35 copies will be given to all committee members for their use in reviewing the study.
Consent Forms A sample consent form for drug trials is available by clicking here .
I understand the purpose of the study as well as the potential benefits and risks that are involved. I hereby give my informed and free consent to be a participant in this study. I have been given a copy of this consent form. However, the Principal Investigator and this institution have made no provision to reimburse you for the cost of medical care beyond emergency medical treatment or to pay for any lost wages, pain and suffering, hospitalization, or other expenses you may incur as the result of any such complication, injury, or illness. A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.